RU2021106290A - VETERINARY MEDICINE INTENDED FOR THE TREATMENT OF CATS WITH INFECTIOUS (VIRAL) PERITONITIS - Google Patents
VETERINARY MEDICINE INTENDED FOR THE TREATMENT OF CATS WITH INFECTIOUS (VIRAL) PERITONITIS Download PDFInfo
- Publication number
- RU2021106290A RU2021106290A RU2021106290A RU2021106290A RU2021106290A RU 2021106290 A RU2021106290 A RU 2021106290A RU 2021106290 A RU2021106290 A RU 2021106290A RU 2021106290 A RU2021106290 A RU 2021106290A RU 2021106290 A RU2021106290 A RU 2021106290A
- Authority
- RU
- Russia
- Prior art keywords
- cats
- treatment
- peritonitis
- infectious
- viral
- Prior art date
Links
- 206010034674 Peritonitis Diseases 0.000 title claims 3
- 230000002458 infectious Effects 0.000 title 1
- 230000003612 virological Effects 0.000 title 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 4
- 241000282326 Felis catus Species 0.000 claims 2
- 229940068918 Polyethylene Glycol 400 Drugs 0.000 claims 2
- 235000019441 ethanol Nutrition 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 239000002777 nucleoside Substances 0.000 claims 2
- 150000003833 nucleoside derivatives Chemical class 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000008215 water for injection Substances 0.000 claims 2
- 229920000858 Cyclodextrin Polymers 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- -1 hydroxypropyl Chemical group 0.000 claims 1
Claims (2)
Publications (1)
Publication Number | Publication Date |
---|---|
RU2021106290A true RU2021106290A (en) | 2022-09-12 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2860526T3 (en) | Preserved Etherified Cyclodextrin Derivatives Containing A Liquid Aqueous Pharmaceutical Composition | |
RU2470016C2 (en) | Bipirazole derivative | |
CY1111159T1 (en) | CONCENTRATED Methotrexate Solutions | |
JP2015527402A5 (en) | ||
AR063150A1 (en) | STABLE FORMULATIONS | |
BRPI0413756A (en) | compound, methods for treating or preventing spasticity or a symptom of spasticity, gastro-oesophageal reflux disease, drug addiction, alcohol addiction or abuse, or nicotine abuse or addiction, and cough or emesis in a patient, and, pharmaceutical composition | |
UY26779A1 (en) | PRODROGAS 3` DE 2 '-DESOXI-B-L-NUCLEÓSIDOS | |
HUT75684A (en) | Parenteral solutions of diclofenac salts | |
BRPI0616536B8 (en) | use of a hydroxybenzoic acid ester | |
RU2009123536A (en) | Stable parenteral formulations, including benzodiazepine-based PCB inhibitors | |
GT200600263A (en) | DOSAGE REGIME FOR PRASUGREL | |
JP2015510882A5 (en) | ||
ES2403121T3 (en) | Formulation of injectable paracetamol, stable, ready to use | |
CY1124236T1 (en) | LEVONTOPA INJECTION SOLUTION | |
DK1502589T3 (en) | Veterinary aqueous injectable suspensions containing florfenicol | |
RU2021106290A (en) | VETERINARY MEDICINE INTENDED FOR THE TREATMENT OF CATS WITH INFECTIOUS (VIRAL) PERITONITIS | |
EA202193240A1 (en) | STABILIZED COMPOSITIONS CONTAINING ANTI-ANGPTL3 ANTIBODIES | |
FI3672631T3 (en) | Pharmaceutical compositions containing anti-beta amyloid antibodies | |
JP2016534062A5 (en) | ||
EP4249069A3 (en) | Aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea | |
AR119805A1 (en) | AQUEOUS PHARMACEUTICAL COMPOSITION OF PROLGOLIMAB ANTI-PD1 ANTIBODY AND ITS USE | |
US20030005889A1 (en) | Method of improving hatchability of eggs | |
PA8682701A1 (en) | FORMULATION OF PROLONGED RELEASE OF ACTIVE PRINCIPLES OF MEDICINES | |
MD3121F1 (en) | Method of viral hepatitis B prophylaxis | |
ES2369296T3 (en) | CONCENTRATED LIQUID COMPOSITION OF THYROID HORMONE. |